E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/17/2009 in the Prospect News PIPE Daily.

New Issue: ALDA Pharmaceuticals announces C$1.5 million private placement of units

By Devika Patel

Knoxville, Tenn., July 17 - ALDA Pharmaceuticals Corp. said it will conduct a C$1.5 million private placement of units.

The company will sell 6 million units of one common share and one warrant at C$0.25 apiece. Each warrant is exercisable at C$0.40 for one year.

ALDA, based in Vancouver, B.C., has developed a family of wide spectrum, non-toxic, non-corrosive, biodegradable infection control products based on its patent-pending T(3)6(R) technology.

Issuer:ALDA Pharmaceuticals Corp.
Issue:Units of one common share and one warrant
Amount:C$1.5 million
Units:6 million
Price:C$0.25
Warrants:One warrant per unit
Warrant expiration:One year
Warrant strike price:C$0.40
Pricing date:July 17
Stock symbol:TSX Venture: APH
Stock price:C$0.33 at close July 17
Market capitalization:C$16.5 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.